Systematic surveillance of immune-related adverse events in clinical practice and impact of subsequent steroid medication on survival outcomes

ConclusionSteroid treatment for irAE does not affect prognosis and should thus be used promptly to control inflammation. However, pulse therapy for severe cases is a poor prognostic factor, and early detection remains the key to managing such irAEs. The irAE characteristics in each regimen should be clarified to establish and provide more sophisticated irAE management, and the current findings will be beneficial to this goal.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research